Sabari JK, Yu HA, Mahadevia PJ, Liu Y, et al. Overall Survival in EGFR-mutant Advanced Non-Small Cell Lung Cancer Treated with First-line Osimertinib: A Cohort Study Integrating Clinical and Biomarker Data in the United States. J Thorac Oncol 2025 May 2:S1556-0864(25)00699.
PMID: 40320171